191.034 articles found

Treadmill exercise intervention improves gait and postural control in alpha-synuclein mouse models without inducing cerebral autophagy.

Minakaki G, Canneva F, Chevessier F, Bode F, Menges S, Timotius IK, Kalinichenko LS, Meixner H, Müller CP, Eskofier BM, Casadei N, Riess O, Schröder R, Winkler J, Xiang W, von Hörsten S, Klucken J.

Behav Brain Res · 2018-12-30

DOI: 10.1016/j.bbr.2018.11.035PMID: 30599154

Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France.

Bénard-Laribière A, Noize P, Girodet PO, Lassalle R, Dureau-Pournin C, Droz-Perroteau C, Fourrier-Réglat A, Salvo F, Bezin J, Pariente A, DRUGS-2M study group.

Therapie · 2018-12-30

DOI: 10.1016/j.therap.2018.12.007PMID: 30857740

NÖROLOJİK HASTALIKLARDA DÜŞME

Hanağası, Haşmet

Ege Tıp Bilimleri Dergisi, Vol. 1 No. 4 · 2018-12-29

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's Disease.

Ueno SI, Saiki S, Fujimaki M, Takeshige-Amano H, Hatano T, Oyama G, Ishikawa KI, Yamaguchi A, Nojiri S, Akamatsu W, Hattori N.

Cells · 2018-12-29

DOI: 10.3390/cells8010014PMID: 30597973

Mitochondrial function and abnormalities implicated in the pathogenesis of ASD.

Castora FJ.

Prog Neuropsychopharmacol Biol Psychiatry · 2018-12-29

DOI: 10.1016/j.pnpbp.2018.12.015PMID: 30599156

Evaluation of Comorbidities in Patients with Autoimmune Bullous Diseases: A Retrospective Study.

Karabay EA, Çerman AA, Altunay İK.

Sisli Etfal Hastan Tip Bul · 2018-12-28

DOI: 10.14744/semb.2018.55376PMID: 32774095

Chiral Molecule-mediated Porous Cu _xO Nanoparticle Clusters with Antioxidation Activity for Ameliorating Parkinson's Disease.

Hao C, Qu A, Xu L, Sun M, Zhang H, Xu C, Kuang H.

J Am Chem Soc · 2018-12-28

DOI: 10.1021/jacs.8b11856PMID: 30540450

An internal ribosome entry site in the coding region of tyrosyl-DNA phosphodiesterase 2 drives alternative translation start.

Chou AC, Aslanian A, Sun H, Hunter T.

J Biol Chem · 2018-12-28

DOI: 10.1074/jbc.ra118.006269PMID: 30593505

Wild-type and mutant (G2019S) leucine-rich repeat kinase 2 (LRRK2) associate with subunits of the translocase of outer mitochondrial membrane (TOM) complex.

Neethling A, Engelbrecht L, Loos B, Kinnear C, Theart R, Abrahams S, Niesler T, Mellick GD, Williams M, Bardien S.

Exp Cell Res · 2018-12-28

DOI: 10.1016/j.yexcr.2018.12.022PMID: 30597143

Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.

Irvine MW, Fang G, Sapkota K, Burnell ES, Volianskis A, Costa BM, Culley G, Collingridge GL, Monaghan DT, Jane DE.

Eur J Med Chem · 2018-12-28

DOI: 10.1016/j.ejmech.2018.12.054PMID: 30622023

Serotonergic dysfunction in a model of parkinsonism induced by reserpine.

Leal PC, Bispo JMM, Engelberth RCGJ, de A Silva KD, Meurer YR, Ribeiro AM, Silva RH, Marchioro M, Santos JR.

J Chem Neuroanat · 2018-12-28

DOI: 10.1016/j.jchemneu.2018.12.011PMID: 30597197

The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2.

Huang X, Wu C, Park Y, Long X, Hoang QQ, Liao J.

FASEB J · 2018-12-28

DOI: 10.1096/fj.201802031rPMID: 30592623